Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recombinant Sgp130 attenuates alkali-burn cornea through inhibition of IL-6 trans-signaling: From production to therapeutic application.

International journal of biological macromolecules·2026
Same author

The entropic view of aging: from thermodynamics to biology.

Life medicine·2026
Same author

Mechanisms and interventions of epigenetic aging.

Cell chemical biology·2026
Same author

Intervening in aging and related diseases with gene therapy techniques.

Cell reports. Medicine·2026
Same author

Single-nucleus interrogation of primate small intestinal aging reveals NCoR1 decline as a conserved feature that is reversed by metformin.

Nature aging·2026
Same author

Author Correction: CHIT1-positive microglia drive motor neuron ageing in the primate spinal cord.

Nature·2026

Related Experiment Video

Updated: May 14, 2026

Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures
08:32

Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures

Published on: March 27, 2019

hESC-derived pancreatic progenitors.

Lina Sui1, Guang-Hui Liu, Juan Carlos Izpisua Belmonte

  • 1National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

Cell Research
|February 6, 2013
PubMed
Summary

Human embryonic stem cell-derived pancreatic progenitors (PPs) offer a promising alternative transplantable source for cell replacement therapy. Research explores their differentiation and transplantation for diabetes treatment.

More Related Videos

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

Related Experiment Videos

Last Updated: May 14, 2026

Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures
08:32

Efficient Generation of Pancreas/Duodenum Homeobox Protein 1+ Posterior Foregut/Pancreatic Progenitors from hPSCs in Adhesion Cultures

Published on: March 27, 2019

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
09:23

Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors

Published on: March 7, 2017

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
10:12

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System

Published on: December 16, 2021

Area of Science:

  • Stem cell biology
  • Endocrinology
  • Regenerative medicine

Background:

  • Type 1 diabetes requires effective beta cell replacement therapy.
  • Human embryonic stem cells (hESCs) can be differentiated into pancreatic cells.
  • Current therapies face challenges with beta cell availability and function.

Purpose of the Study:

  • To explore the potential of hESC-derived pancreatic progenitors (PPs) as a transplantable source.
  • To review current and future strategies for beta cell differentiation and transplantation.
  • To evaluate PPs as an alternative to differentiated beta cells in therapy.

Main Methods:

  • In vitro derivation of pancreatic progenitors from hESCs.
  • In vivo differentiation studies of PPs.
  • Review of existing research in beta cell biology and transplantation.

Main Results:

  • Successful derivation of PPs from hESCs is demonstrated.
  • PPs show potential for differentiation into functional beta cells in vivo.
  • PPs represent a viable alternative transplantable source.

Conclusions:

  • hESC-derived PPs are a promising alternative for beta cell replacement therapy.
  • Further research in differentiation and transplantation is warranted.
  • This approach could advance diabetes treatment strategies.